Cargando…

CMV Colitis: A Rare Complication of Azacitidine and Venetoclax Chemotherapy

Herein, we present a case of cytomegalovirus (CMV) colitis that occurred after two cycles of azacitidine and venetoclax in a 64-year-old woman affected with acute myeloid leukaemia (AML) secondary to a previous diagnosis of a hypoplastic myelodysplastic syndrome (hypo-MDS). This patient never had de...

Descripción completa

Detalles Bibliográficos
Autores principales: Bankur, Mustafa Nissar, Keeling, Archie, Adil Shah, Khoodoruth Mohamed, Avenoso, Daniele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326678/
https://www.ncbi.nlm.nih.gov/pubmed/35893153
http://dx.doi.org/10.3390/hematolrep14030029
_version_ 1784757344090980352
author Bankur, Mustafa Nissar
Keeling, Archie
Adil Shah, Khoodoruth Mohamed
Avenoso, Daniele
author_facet Bankur, Mustafa Nissar
Keeling, Archie
Adil Shah, Khoodoruth Mohamed
Avenoso, Daniele
author_sort Bankur, Mustafa Nissar
collection PubMed
description Herein, we present a case of cytomegalovirus (CMV) colitis that occurred after two cycles of azacitidine and venetoclax in a 64-year-old woman affected with acute myeloid leukaemia (AML) secondary to a previous diagnosis of a hypoplastic myelodysplastic syndrome (hypo-MDS). This patient never had detectable CMV viraemia, and there was no evidence of immune deficiency that could justify this opportunistic infection. Additionally, this is most likely the first report describing CMV colitis in a patient treated upfront with azacitidine and venetoclax.
format Online
Article
Text
id pubmed-9326678
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-93266782022-07-28 CMV Colitis: A Rare Complication of Azacitidine and Venetoclax Chemotherapy Bankur, Mustafa Nissar Keeling, Archie Adil Shah, Khoodoruth Mohamed Avenoso, Daniele Hematol Rep Case Report Herein, we present a case of cytomegalovirus (CMV) colitis that occurred after two cycles of azacitidine and venetoclax in a 64-year-old woman affected with acute myeloid leukaemia (AML) secondary to a previous diagnosis of a hypoplastic myelodysplastic syndrome (hypo-MDS). This patient never had detectable CMV viraemia, and there was no evidence of immune deficiency that could justify this opportunistic infection. Additionally, this is most likely the first report describing CMV colitis in a patient treated upfront with azacitidine and venetoclax. MDPI 2022-06-23 /pmc/articles/PMC9326678/ /pubmed/35893153 http://dx.doi.org/10.3390/hematolrep14030029 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Case Report
Bankur, Mustafa Nissar
Keeling, Archie
Adil Shah, Khoodoruth Mohamed
Avenoso, Daniele
CMV Colitis: A Rare Complication of Azacitidine and Venetoclax Chemotherapy
title CMV Colitis: A Rare Complication of Azacitidine and Venetoclax Chemotherapy
title_full CMV Colitis: A Rare Complication of Azacitidine and Venetoclax Chemotherapy
title_fullStr CMV Colitis: A Rare Complication of Azacitidine and Venetoclax Chemotherapy
title_full_unstemmed CMV Colitis: A Rare Complication of Azacitidine and Venetoclax Chemotherapy
title_short CMV Colitis: A Rare Complication of Azacitidine and Venetoclax Chemotherapy
title_sort cmv colitis: a rare complication of azacitidine and venetoclax chemotherapy
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326678/
https://www.ncbi.nlm.nih.gov/pubmed/35893153
http://dx.doi.org/10.3390/hematolrep14030029
work_keys_str_mv AT bankurmustafanissar cmvcolitisararecomplicationofazacitidineandvenetoclaxchemotherapy
AT keelingarchie cmvcolitisararecomplicationofazacitidineandvenetoclaxchemotherapy
AT adilshahkhoodoruthmohamed cmvcolitisararecomplicationofazacitidineandvenetoclaxchemotherapy
AT avenosodaniele cmvcolitisararecomplicationofazacitidineandvenetoclaxchemotherapy